MaxCyte, Inc. (MXCT) short interest & options flow
NASDAQMXCT reported Q1 2026 results on May 12 that cleared the revenue bar — yet the stock barely moved, closing at $0.82 and down about 2.4% on the week. That disconnect between an in-line print and a sub-$1 share price captures the central tension here: management is executing to plan, but the market is paying close to nothing for a business with a $100 million SPL milestone pipeline…
- Market cap
- $123M
- Next earnings
- 25 Mar 2027
Key data as of 13 Nov 2026

MXCT news and analysis
RSSNo long-form analysis yet for MXCT. Pulse alerts and the live data picture are available on ORTEX.
Open MXCT on ORTEX →Want the live picture for MXCT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MXCT — free to start on ORTEX.
Sign up for free →Open MXCT on ORTEX